Get started
Author

Miriam Akasbi

Observed names: Akasbi, Miriam, M Akasbi, M. Akasbi, M. Akasbi-Montalvo, Mirian Akasbi-Montalvo
Observed institutions: Brigham and Women's Hospital, Harvard University, Universidad de Alcalá, Hospital General Universitario Gregorio Marañón, Yale University, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Agència de Gestió d'Ajuts Universitaris i de Recerca, Hospital Clínic de Barcelona, Corporació Sanitària Parc Taulí, Instituto Ramón y Cajal de Investigación Sanitaria, Vall d'Hebron Hospital Universitari, Hospital Universitario Central de Asturias, Cardiovascular Research Foundation, European League Against Rheumatism, Hospital Universitario De Cabueñes, Hospital Universitari Germans Trias i Pujol, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Complejo Hospitalario de Ourense, Hospital Universitario Infanta Leonor, Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer, Universidad Católica de Murcia, Universitat de Barcelona
ORCID: 0000-0001-5888-4409
Observed ORCID: 0000-0001-5888-4409
OpenAlex ID: A5035453916
Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry)
2013 · M. Ramos-Casals, P. Brito-Zeron, et al. · Lara D. Veeken · 255
PDF
Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients
2014 · P Brito-Zerón, B Kostov, et al. · Annals of the Rheumatic Diseases · 204
Characterization and risk estimate of cancer in patients with primary Sjögren syndrome
2017 · on behalf of the SS Study Group GEAS-SEMI, Pilar Brito-Zerón, et al. · Journal of Hematology & Oncology · 153
PDF
Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis
2020 · B. Mestre-Gómez, R. M. Lorente-Ramos, et al. · Journal of Thrombosis and Thrombolysis · 99
PDF
Cardiovascular risk factors in primary Sjögren's syndrome: a case-control study in 624 patients
2010 · M. Pérez-De-Lis, M. Akasbi, et al. · Lupus · 99
Monoclonal gammopathy related to Sjögren syndrome: A key marker of disease prognosis and outcomes
2012 · Pilar Brito-Zerón, Soledad Retamozo, et al. · Journal of Autoimmunity · 92
Annular erythema in primary Sjögren’s syndrome: description of 43 non-Asian cases
2013 · P Brito-Zerón, S Retamozo, et al. · Lupus · 57
Bronchiectasis in primary Sjögren's syndrome: prevalence and clinical significance.
2010 · M-J Soto-Cardenas, M Perez-De-Lis, et al. · PubMed · 53
Classification and characterisation of peripheral neuropathies in 102 patients with primary Sjögren's syndrome.
2013 · Pilar Brito-Zerón, Miriam Akasbi, et al. · PubMed · 49
White matter abnormalities in primary Sjogren syndrome
2011 · M. Akasbi, J. Berenguer, et al. · QJM · 49
Sjögren Syndrome or Sjögren Disease? The Histological and Immunological Bias Caused by the 2002 Criteria
2009 · Manuel Ramos-Casals, Pilar Brito-Zerón, et al. · Clinical Reviews in Allergy & Immunology · 49
Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
2013 · Soledad Retamozo, Miriam Akasbi, et al. · PubMed · 44
PDF
Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study
2023 · Pilar Brito-Zerón, Alejandra Flores-Chávez, et al. · EClinicalMedicine · 42
PDF
Clinical characterization and outcomes of 85 patients with neurosarcoidosis
2021 · Manuel Ramos-Casals, Roberto Pérez-Alvarez, et al. · Scientific Reports · 41
Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients
2021 · Pilar Brito-Zerón, Roberto Pérez-Alvarez, et al. · Joint Bone Spine · 40
PDF
Prevalence and Clinical Relevance of Autoimmune Neutropenia in Patients with Primary Sjögren's Syndrome
2008 · Pilar Brito-Zerón, Natalia Soria, et al. · Seminars in Arthritis and Rheumatism · 39
Systemic phenotype of sarcoidosis associated with radiological stages. Analysis of 1230 patients
2019 · R. Pérez-Alvarez, P. Brito-Zerón, et al. · European Journal of Internal Medicine · 33
How are we treating our systemic patients with primary Sjögren syndrome? Analysis of 1120 patients
2015 · H. Gheitasi, B. Kostov, et al. · International Immunopharmacology · 31
Post-COVID-19 syndrome in patients with primary Sjögren's syndrome after acute SARS-CoV-2 infection
2021 · Pilar Brito-Zerón, Nihan Acar-Denizli, et al. · Clinical and Experimental Rheumatology · 30
PDF
DVT Management and Outcome Trends, 2001 to 2014
2016 · Raquel Morillo, David Jiménez, et al. · CHEST Journal · 25
PDF
Characterization and Outcomes of SARS-CoV-2 Infection in Patients with Sarcoidosis
2021 · P. Brito-Zerón, B. Gracia-Tello, et al. · Viruses · 21
PDF
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients
2020 · Pilar Brito-Zerón, Sheila Melchor, et al. · Lara D. Veeken · 21
PDF
Post-COVID-19 syndrome in patients with primary Sjögren's syndrome after acute SARS-CoV-2 infection.
2021 · Pilar Brito-Zerón, Nihan Acar-Denizli, et al. · PubMed · 18
Impact of Systemic Corticosteroids on Mortality in Older Adults With Critical COVID-19 Pneumonia
2021 · Esther Piniella-Ruiz, María Teresa Bellver-Álvarez, et al. · The Journals of Gerontology Series A · 13
PDF
Exposure to air pollution as an environmental determinant of how Sjögren's disease is expressed at diagnosis
2023 · Pilar Brito-Zerón, Alejandra Flores-Chávez, et al. · Clinical and Experimental Rheumatology · 11
PDF
Works count: 55
Citation count: 1,660
H-index: 21
I10-index: 27
Year
Topic
Type